Tomoki Kubota

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma

Richard S. Finn, Masafumi Ikeda, Andrew X. Zhu et al. · Journal of Clinical Oncology · 2020 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +17

A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEM) in patients (pts) with unresectable hepatocellular carcinoma (uHCC).

Masafumi Ikeda, Max W. Sung, Masatoshi Kudo et al. · Journal of Clinical Oncology · 2018 · 124 citations

Medicine, Oncology, Pharmacology +14

Tissue Characterization of Coronary Plaques Comparison of Integrated Backscatter Intravascular Ultrasound With Virtual Histology Intravascular Ultrasound

Munenori Okubo, Masanori Kawasaki, Yoshiyuki Ishihara et al. · Circulation Journal · 2008 · 121 citations · Full text

Medicine, Cardiology, Pathology +17

Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome

Hideki Itoh, Tomoko Sakaguchi, Wei‐Guang Ding et al. · Circulation Arrhythmia and Electrophysiology · 2009 · 115 citations · Full text

Medicine, Cardiology, Genetics +15

A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma

Toyoaki Hida, Vamsidhar Velcheti, Karen L. Reckamp et al. · Lung Cancer · 2019 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17